4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Market Cap $126.0M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Saunders International Limited
| Forum | Tag | Subject | View | Poster | |||||
|---|---|---|---|---|---|---|---|---|---|
| ASX - By Stock | SND | Ann: Corporate Governance Statement | Thread |
 ASX News
|
0 | 27 | 0 | 17/04/18 | |
|
|||||||||
| ASX - By Stock | SND | Ann: Appendix 3B | Thread |
ASX News
|
0 | 96 | 0 | 08/03/18 | |
|
|||||||||
| ASX - By Stock | SND | Ann: Appendix 3B | Thread |
ASX News
|
0 | 77 | 0 | 08/03/18 | |
|
|||||||||
| ASX - By Stock | SND | Ann: Change of Director's Interest | Thread |
ASX News
|
0 | 86 | 0 | 08/03/18 | |
|
|||||||||
| ASX - By Stock | SND | Ann: Change in substantial holding | Thread |
ASX News
|
0 | 88 | 0 | 27/02/18 | |
|
|||||||||
